Dr. Abdul Muqtadir Abbasi/LinkedIn
Dec 9, 2025, 13:25
Dr. Abdul Muqtadir Abbasi: The Effect of Recombinant Factor VIIa Treatment in Non-Traumatic Intracranial Hemorrhage
Dr. Abdul Muqtadir Abbasi, Assistant Consultant at King Faisal Specialist Hospital and Research Center, shared a post on LinkedIn:
“My Abstract in Blood.”
Title: The effect of recombinant factor VIIa treatment in non-traumatic intracranial hemorrhage: Systematic review and meta-analysis
Authors: Dalal Aldhafeeri, Mohammed Almakadi, Anila K N, Saraswathy S Nair, Sadin Alamri, Aseel Alamri, Manal Alzahrani, Nouf Eldabai, Hassan Alharbi, Gutaybah Alqarni, Abdul Muqtadir Abbasi, Zubair Mohamed, Mohammad Ebraheem

Read full study here.
Follow the latest in Hemostasis Today.
Abdul Muqtadir Abbasi
American Society of Hematology (ASH)
Anila K N
Aseel Alamri
ASH2025
ASH25
Blood
Dalal Aldhafeeri
factor VIIa
Gutaybah Alqarni
Hassan Alharbi
Health
Hematology
Hemostasis
Hemostasis Today
Intracranial Hemorrhage
Manal Alzahrani
Medicine
Mohammad Ebraheem
Mohammed Almakadi
Nouf Eldabai
Sadin Alamri
Saraswathy S Nair
Zubair Mohamed
-
Mar 16, 2026, 17:12Cold-Stored vs Room-Temperature Platelets in Trauma-Induced Coagulopathy – JTH
-
Mar 16, 2026, 17:10Arturo Cesaro: First Meta-Analysis on the Vascular Protective Role of Semaglutide in PAD
-
Mar 16, 2026, 17:01Jeff Sternlicht: The Most Powerful Time to Lower Cholesterol Is Before Anyone Thinks You Need It
-
Mar 16, 2026, 16:14Siobhan Calafiore: Clinical Advantages of Apixaban Over Rivaroxaban in Reducing Bleeding Risk
-
Mar 16, 2026, 16:12Nuha El Sayed: Focused Summary of the 2026 ACC/AHA Guideline on Management of Dyslipidemia in Diabetes
-
Mar 16, 2026, 16:08Deepak Sudheendra: When a Vascular Looking Skin Pattern Isn’t Vascular
-
Mar 16, 2026, 16:06Surendra Karki։ Examining Blood Type and Coronary Heart Disease Risk in Australian Donors
-
Mar 16, 2026, 15:58Alan Nurden: Genome-Wide Analyses Unravel the Genetic Architecture of Coagulation and Fibrinolysis
-
Mar 16, 2026, 15:56Emmanuel J. Favaloro: Latest Publication from Sydney Centres on Heparin Therapy and Monitoring